Summary
It seems evident that fibrinogen and fibrin representing the final substrate und product of clotting system act as pathogenetic connecting links for development and spread of malignant tumors. The results reported demonstrate the influence of fibrin on the initial phase of haematogenic metastasis particularly. Several tumor-specific mechanisms are shown to cause frequently an accumulation of fibrin in malignant tumors. The results discussed here stress the importance of fibrin in tumors for tumor cells and tumor cell units. In the literature a large number of indications to fibrin depositions in experimental tumors is found, an attempt is made to compare these findings semiquantitatively. The last part of this article discusses the therapeutic and diagnostic consequences based on the possible key position of fibrin(ogen) in the tumor pathology.
Zusammenfassung
Fibrinogen und Fibrin, Endsubstrat und Endprodukt des Gerinnungssystems, scheinen bei der Entwicklung und Ausbreitung von Malignomen die Rolle eines pathogenetischen Bindegliedes zu spielen. In der Literatur zeigen die Forschungsergebnisse, daß Fibrin insbesondere in die Initialphase der hämatogenen Metastasierung eingreift. Für die häufig anzutreffende, oft reichliche Fibrinablagerung in Tumoren konnten mehrere tumorspezifische Mechanismen nachgewiesen werden. Die Ergebnisse der zitierten Forschungsarbeiten weisen auf die Bedeutung des intratumorös abgelagerten Fibrins für Tumorzelle und -zellverband hin. Die von verschiedenen Autoren berichteten Fibrinanreicherungen in tierexperimentellen Tumoren werden semiquantitativ verglichen. Die Diskussion der therapeutischen und diagnostischen Konsequenzen, die auf einer möglichen Schlüsselstellung des Fibrin(ogen)s in der Tumorpathologie beruhen, zeigt bekannte und noch zu untersuchende Möglichkeiten.
Similar content being viewed by others
Literatur
Agostino, D., Cliffton, E.E.: Decrease in pulmonary metastases: potentiation of nitrogen mustard effect by heparin and fibrinolysin. Ann. Surg.157, 400 (1963)
Astrup, T.: Interrelation between inhibitors of blood coagulation and of fibrinolysis. Thrombos. Diathes. haemorrhag. Suppl.7, 62 (1962)
Austin, J.P., Glaser, E.M.: Inhibition of experimental tumors by defibrinogenation. Clin. Sci.37, 878 (1969)
Back, N., Shields, R.R., Dewitt, H.G., Branshaw, R.H., Ambrus, C.M.: Uptake of fibrinogen and fibrinolytic enzymes by neoplastic tissue. J. Nat. Cancer Inst.36, 171 (1966)
Baillie, A.J., Sim, A.K.: Activation of the fibrinolytic enzyme systeme in laboratory animals and in man—a comparative study. Thrombos. Diathes. haemorrhag.25, 499 (1971)
Bale, W.F., Spar, J.L., Goodland, R.L.: Experimental radiation therapy of tumors with I-131-carrying antibodies to fibrin. Cancer Res.20, 1488 (1960)
Bale, W.F., Spar, J.L., Goodland, R.L.: Research directed toward the use of 131-I-labeled fibrinogen and antibody to fibrin in the localisation and treatment of tumors. Proc. Conf. on use of Radioisotopes in Animal Biology and the Med. Sciences, Mexico City2, 271 (1961)
Beller, F.K., Ruhrmann, G.: Zur Pathogenese des Kasabach-Merritt-Syndroms. Klin. Wschr.37, 1078 (1959)
Bergentz, S.E., Gelin, L.E., Rudenstam, C.M.: Microcirculation in tumors. Acta Chir. Scand.125, 443 (1963)
Berkarda, F.B., D'Souza, J.P., Bakemeier, R.F.: The effect of anticoagulants on tumor growth and spread in mice. Proc. Amer. Ass. Cancer Res.15, 99 (1974)
Boggust, W.A., O'Brien, D.J., O'Meara, R.A.Q., Thornes, R.D.: The coagulative factors of normal human and human cancer tissue. Irish J. Med. Sci.447, 131 (1963)
Caullo, T., Sade, R., Folkman, J., Cotran, R.S.: Ultrastructural autoradiographic studies of the early vasoproliferative response in tumor angiogenesis. Amer. J. Pathol.70, 345 (1973)
Cavallo, T., Sade, R., Folkman, J., Cotran, R.S.: Tumor angiogenesis. J. Cell Biol.54, 408 (1972)
Cliffton, E.E., Grossi, C.E.: Effect of human plasmin on the toxic effects and growth of bloodborne metastases of the Brown-Pearce carcinoma and the V2 carcinoma of rabbit. Cancer9, 1147 (1956)
Cliffton, E.E., Agostino, D.: Cancer cells in the blood in simulated colon cancer, resectable and unresectable: effect of fibrinolysin and heparin on growth potential. Surgery50, 395 (1961)
Cliffton, E.E., Agostino, D.: The effects of fibrin formation and alterations in the clotting mechanism on the development of metastasis. J. vascular Dis.2, 43 (1965)
Dahl, S.: Treatment of cancer patients with infusion of plasmin. Oncologia20, 35 (1966)
Day, E.D., Planinski, A.J., Korngold, F., Pressman, D.: Tumor-localizing antibodies purified from antisera against Murphy rat lymphosarcoma. J. Nat. Cancer Inst.17, 517 (1956)
Day, E.D., Planinski, A.J., Pressman, D.: Lokalisation of radioiodinated rat fibrinogen in transplanted rat tumors. J. Nat. Cancer Inst.23, 799 (1959)
Di Chiro, G., Spar, J.L., Bale, W.F.: RIAF-radioiodinated anti-fibrinogen encephalography. Acta Radiol.1, 967 (1963)
Duckert, F.: Documentation of the plasma factor XIII deficiency in man. Ann. N.Y. Acad. Sci.202, 190 (1972)
Fisher, B., Fisher, E.R.: Experimental evidence in support of the dormant cancer cell. Science130, 918 (1959)
Fisher, B., Fisher, E.R.: Exp. studies of factors which influence hepatic metastases. VIII. Effect of anticoagulants. Surgery50, 240 (1961)
Fisher, B., Fisher, E.R.: The interrelationship of hematogenous and lymphatic tumor cell dissemination. Surg. Gynec. Obstet.17, 791 (1966)
Fumarola, D., Marcuccio, L., Restuccia, P., la Pesa, M.: Influenza della coagulasi stafilococcica sulla insorgenza e sullo sviluppo del reticolosarcoma IRE solido del ratto. Pathologica63, 215 (1971)
Gastpar, H., Graeber, F., Herrmann, A., Loebell, E.: Intravitalmikroskopische Betrachtungen von Tumorzellen in der Blutbahn. Arch. Ohr-, Nas.-, Kehlk.-Heilk.178, 534 (1961)
Gastpar, H.: Metastasierung und Blutgerinnung. Thrombos. Diathes. Haemorrh. Suppl.28, 119 (1968)
Gittermann, C.O., Luell, S.: Chemotherapeutic studies on metastasis of human epidermoid carcinoma No. 3 in the embryonated egg. In: Chemotherapy of cancer dissemination and metastasis, ed. Garattini and Franchi, p. 279, New York: Raven 1973
Goodnight, J.: Bleeding and intravascular clotting in malignancy: A review. Ann. N.Y. Acad. Sci.230, 271 (1974)
Griffiths, J.D., Salsbury, A.J.: The fate of circulating Walker-256-tumor cells injected intravenously in rats. Brit. J. Cancer17, 546 (1963)
Grossi, D.E., Agostino, D., Cliffton, E.E.: The effect of human fibrinolysin on pulmonary metastases of Walker-256-Carcinosarkoma. Cancer Res.20, 605 (1960)
Gullino, P.M., Grantham, F.H., Smith, S.H.: The interstitial water space of tumors. Cancer Res.25, 727 (1965)
Hadfield, G.: The dormant cancer cell. Brit. med. J.2, 407 (1954)
Hagmar, B.: Experimental tumor metastases and blood coagulability. Acta path. microbiol. scand. Suppl. 211 (1970)
Hall, J.B.: Evolution of the prokaryotes. J. theor. Biol.30, 429 (1971)
Hamperl, H.: Über die Gutartigkeit und Bösartigkeit von Geschwülsten. Verh. dtsch. Ges. Path.35, 29 (1952)
Harpel, P.C., Mosesson, M.W.: Degradation of human fibrinogen by α-2-macroglobulin-enzyme complexes. J. clin. Invest.52, 2175 (1973)
Heilbrunn, L.V., Wilson, W.L.: The effect of heparin on cell division. Proc. Soc. exp. Biol.70, 179 (1949)
Heyes, H., Hilgard, P., Sigmund, E., Hiemeyer, V.: Untersuchungen zur 131-J-Fibronogen-Aufnahme durch das Yoshida-Sarkom der Ratte. Fortschr. Röntgenstr.118, 86 (1973)
Hiemeyer, V., Merkle, P.: Über den Einfluß von Plasmin auf die Metastasierung von Impftumoren der Ratte. Z. Krebsforsch.70, 325 (1968)
Hilgard, P., Heyes, H., Sigmund, E., Hiemeyer, V.: Untersuchungen zur thromboplastischen Aktivität, Fibrinolyse und Ausfällung von 131-J-Fibrinogen bei verschiedenen experimentellen Tumoren. Fortschr. Röntgenstr.113, 96 (1970)
Hilgard, P., Hiemeyer, V., Sigmund, E., Heyes, H.: Tierexperimentelle Untersuchungen zum Tumornachweis mit 131-J-Fibrinogen. In: Ergebnisse Klin. Nuklearmed., ed. Horst, W., Pabst, H., Stuttgart-New York: F.K. Schattauer-Verlag 1971
Hilgard, P., Beyerle, L., Hohage, R., Hiemeyer, V., Kübler, M.: The effect of heparin on the initial phase of metastasis formation. Europ. J. Cancer8, 347 (1972)
Hilgard, P.: The role of blood platelets in experimental metastases. Brit. J. Cancer28, 429 (1973)
Hilgard, P., Thornes, R.D.: Anticoagulants in the treatment of cancer. In Vorbereitung
Iwasaki, T.: Histological and exp. observations of destruction of tumor cells in blood vessels. J. Path. Bact.20, 85 (1915)
Johnson, J.H., Wood, S.: An in vivo study of fibrinolytic agents on V2 carcinoma cells and intravascular thrombi in rabbits. Bull. Johns Hopkins Hosp.113, 335 (1963)
Jones, D.S., Wallace, A.C., Fraser, E.E.: Sequents of events in experimental metastases of Walker-256-tumor. Light, immunofluorescent and electron microscopic observations. J. Nat. Cancer Inst.46, 493 (1971)
Kirsch, W.M., Schulz, D., van Burskirk, J.J., Young, H.E.: Effects of sodium warfarin and other carcinostatic agents on malignant cells: A study of drug synergy. J. Med.5, 69 (1973)
Koike, A.: Mechanisms of blood-borne metastases. I. Some factors affecting lodgement and growth of tumor cells in the lung. Cancer17, 450 (1964)
Kost, G.F.W.: Das Schicksal eingeschwemmter Krebszellen in die Lunge. Ztschr. f. Krebsf.43, 291 (1936)
Laki, K., Yancey, S.T.: Fibrinogen and the tumor problem. In: Fibrinogen, ed. Dekker, M., cap. 16, New York: Inc. 1968
Laki, K.: Fibrinogen and metastasis. J. Med.5, 32 (1974)
Laki, K.: Biochemie zur Onkohämostaseologie. 19. Tagg. d. dtsch. Arbeitsgemeinschaft f. Blutgerinnungsforschung, München 1975
Larsen, V., Mogensen, B., Amris, C.J., Storm, D.: Fibrinolytic enzyme in the treatment of patients with cancer. Danish Med. Bull.11, 137 (1964)
Lasch, H.G., Roka, L.: Zur Prothrombinbildung in der Leber. Hoppe-Seylers Z. physiol. Chem.294, 30 (1953)
Lawrence, E.A., Bowman, D.E., Moore, D.B., Bernstein, G.J.: A thromboplastic property of neoplasms. Surg. Forum3, 694 (1953)
Le Serve, A.W., Hellman, K.: Metastasis and the normalization of tumor blood vessels by ICRF 159: A new type of drug action. Brit. Med. J.1, 597 (1972)
Liss, E., Schmidt, F., Ernst, H.: Versuche zur Tumorszintigraphie mit heterologem Fibrinogen nach Markierung mit 131-J. Strahlentherapie117, 223 (1962)
Ludwig, H.: Anticoagulantien beim fortgeschrittenen Carcinom. Gynäkologe7, 204 (1974)
Marx, R.: Klinisch-haemostaseologische Phänomene bei Malignomen. 19. Tagg. d. Dtsch. Arbeitsgem. f. Blutgerinnungsforschg., München 1975
Michaels, L.: Cancer incidence and mortality in patients having anticoagulant therapy. Lancet2, 832 (1964)
Monasterio, G.: Radioactive fibrinogen for the diagnosis of tumors. Bull. de la Soc. Internat. de Chirurgie2, 234 (1964)
Monasterio, G.: Neue Methode der Tumorlokalisation. Wiener Ztschr. f. Inn. Med. u. ihre Grenzgeb.46, 133 (1965)
Mosesson, M.W.: The fibrinogenolytic pathway of fibrinogen catabolism. Thromb. Res.2, 185 (1973)
Ogura, T.: Localisation of fibrinogen in the tumor tissue. Gann58, 403 (1967)
O'Meara, R.A.Q.: Coagulative properties of cancer. Irish J. Med. Sci.394, 474 (1958)
O'Meara, R.A.Q.: The growth-pattern of carcinomas. Arch. De Vecchi Anat. pat.31, 365 (1969)
O'Meara, R.A.Q., Thornes, R.D.: Some properties of the cancer coagulative factor. Irish J. Med. Sci.423, 106 (1961)
Peterson, H.J., Appelgren, K.L., Rudenstam, C.M.: Studies on the circulation of experimental tumors. I. Effect of induced fibrinolysis and antifibrinolysis on capillary blood flow and the capillary transport function of two experimental tumors in the mouse. Europ. J. Cancer5, 91 (1969)
Peterson, H.J., Appelgren, K.L., Rosengreen, B.H.: Experimental studies on the mechanisms of fibrinogen uptake in a rat tumor. Europ. J. Cancer8, 677 (1972)
Peterson, H.J., Appelgren, K.L.: Experimental studies on the uptake and retention of labelled proteins in a rat tumor. Europ. J. Cancer9, 543 (1973)
Pineo, G.F., Regoeczi, E., Hatton, M.W.C., Brain, M.C.: The activation of coagulation by extracts of mucus: A possible pathway of intravascular coagulation accompanying adenocarcinomes. J. Lab. Clin. Med.82, 255 (1973)
Riccioni, N.: The time course of radiofibrinogen uptake in the IRE sarkoma and in acute inflammatory processes induced in rats. Minerva Nucleare9, 250 (1965)
Ries, J., Ludwig, H., Appel, W.: Antikoagulation bei der Strahlenbehandlung weiblicher Genitalkarzinome. I. Mitteilung: Plattenepithelkarzinome. Med. Welt38, 2042 (1968)
Ryan, J.J., Ketcham, A.S., Wexler, H.: Warfarin treatment of mice bearing autochthonous tumors. Effect on spontaneous metastases. Science162, 1493 (1968)
Ryan, J.J., Ketcham, A.S., Wexler, H.: Reduced incidence of spontaneous metastases with longterm Coumadin therapy. Ann. Surg.168, 163 (1968)
Sampson, A.J.: Implantation of peritoneal carcinomatosis of ovarian origin. Amer. J. Path.7, 423 (1931)
Saphir, O.: The fate of carcinoma emboli in the lung. Amer. J. Pathol.23, 245 (1947)
Schmidt, E.H., Song, B., Beller, F.K.: Fibrinolytische Enzymaktivität gynäkologischer Tumoren. 19. Tagg. d. Dtsch. Arbeitsgemeinsch. f. Blutgerinnungsforschg. München 1975
Schmidt, M.B.: Die Verbreitungswege der Karzinome und die Beziehung generalisierter Sarkome zu den leukämischen Neubildungen. Fischer, G. Jena: 1903
Schrägle, M.: Lymphgefäßkarzinome der Lunge bei multipler Krebsembolie der kleinen Lungenarterienäste. Z. Krebsforsch.49, 573 (1940)
Sherman, L.A.: Fibrinogen turnover: Demonstration of multiple pathways of catabolism. J. Lab. Clin. Med.79, 710 (1972)
Sherry, S.: Altered coagulability in tumor patients: Introduction. Ann. New York Acad. Sci.230, 251 (1974)
Slichter, S.J., Harker, L.A.: Hemostasis in malignancy. Ann. New York Acad. Sci.230, 252 (1974)
Spar, J.L., Goodland, R.L., Bale, W.F.: Localisation of I-131 labeled antibody to rat fibrin in transplantable rat lymphosarcoma. Proc. Soc. Exper. Biol. and Med.100, 259 (1959)
Spar, J.L., Bale, W.F.: Distribution of injected I-131 labeled antibody to dog fibrin in tumorbearing dogs. Cancer Res.20, 1501 (1960)
Spar, J.L.: Localisation of I-131 labeled antibodies to fibrinogen in human tumors. Proc. Amer. Ass. Cancer Res.4, 65 (1963)
Spar, J.L.: I-131 labeled antibodies to human fibrinogen. Diagnostic studies and therapeutic trials. Cancer20, 865 (1967)
Stern, A.: Das Schicksal eingeschwemmter Geschwulstzellen in der Lunge. Virch. Arch.241, 219 (1923)
Sträuli, P.: Intravascular clotting and cancer localisation. Thrombos. Diathes. haemorrhag. Suppl.20, 147 (1966)
Sträuli, P.: The barrier function of lymph nodes. A review of experimental studies and their implications for cancer surgery. In: Surgical oncology, ed. Saegesser+Pettavel, pp. 161. Bern: Huber-Verlag 1970
Sträuli, P.: Onkohämostaseologie. Morphologie. 19. Tagg. d. Dtsch. Arbeitsgem. f. Blutgerinnungsforschg., München 1975
Sylven, B., Bois, J.: Protein content and enzymatic assays of interstitial fluid from some normal tissues and transplanted mouse tumors. Cancer Res.20, 831 (1960)
Szent-Györgyi, A.: Steric, electronic and integrative factors in enzyme regulation. Adv. enzyme Regulat.7, 5 (1969)
Takahashi, M.: An experimental study of metastasis. J. Path. Bact.20, 1 (1915)
Terranova, T., Chiossone, F.: Il fattore coagulazione nell'attec-chimento dello cellule neoplastiche immesse in circulo. Boll. Soc. biol. sper.28, 1224 (1952)
Thornes, R.D., O'Meara, R.A.Q.: A method of detecting and estimating inhibitors of the cancer coagulative factor. Irish J. Med. Sci.423, 361 (1961)
Thornes, R.D.: Host factors in neoplasia. Irish J. Med. Sci.6, 265 (1966)
Thornes, R.D.: Anticoagulant therapy in patients with cancer. Irish J. Med. Ass.62, 426 (1969)
Thornes, R.D.: Oral anticoagulant therapy of human cancer. J. Med.5, 83 (1974)
Unkeless, J.C., Tobia, A., Ossowski, L., Quigley, J.P., Rifkin, D.B., Reich, E.: An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J. Exp. Med.137, 85 (1973)
Urbach, F.: The blood supply of tumors: Advances in biology of skin: Vol. 2. Blood vessels and circulation, p. 123. New York: Pergamon press 1961
Varon, M.J., Spar, J.L.: The increase in uptake of 131-I labeled fibrinogen in tumor tissue by modification of the coagulation mechanism of the host. Proc. Amer. Ass. Cancer Res.6, 66 (1965)
Wallach, D.F.H.: Generalized membrane defects in cancer. New Engl. J. Med.280, 761 (1969)
Warren, S., Gates, O.: The fate of intravenously injected tumor cells. Amer. J. Cancer27, 485 (1936)
Watanabe, S.: The metastasizability of tumor cells. Cancer7, 215 (1954)
Winkler, C.: Über die Nutzung gerinnungsphysiologischer und immunologischer Prozesse zur Radioaktivitätsanreicherung in Tumoren. In: Radionuklide in der klin. und experim. Onkologie. pp. 349, Stuttgart: Schatterauer-Verlag 1965
Wood, S., Holyoke, E.D., Yardley, J.H.: An experimental study of the influence of adrenal steroids, growth hormone and anticoagulants on pulmonary metastasis formation in mice. Proc. Amer. Ass. Cancer Res.2, 157 (1956)
Wood, S.: Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber. Arch. Path.66, 550 (1958)
Wood, S.: Mechanism of metastasis production by blood-borne cancer cells. Canad. Cancer Conf.4, 167 (1961)
Wood, S.: Experimental studies of the intravascular dissemination of ascites V2 carcinoma cells in the rabbit, with special reference to fibrinogen and fibrinolytic agents. Swiss Acad. Med. Sci. Bull.20, 92 (1964)
Wood, S.: Mechanisms of establishment of tumor metastases. In: Ioachim Pathobiology annual, pp. 281. New York: Appleton-Century-Crofts 1971
Wood, S., Hilgard, P.: Arvin-induced hypofibrinogenemia and metastasis formation from bloodborne cancer cells. Johns Hopk. Hosp. Med. J.133, 207 (1973)
Wood, S.: Experimental studies on the spread of cancer with special reference to fibrinolytic agents and anticoagulants. J. Med.5, 7 (1974)
Yamamoto, M., Yamad, T., Fukunaga, K., Nagashima, A., Nagamatsu, S., Hioki, K.: Methods to potentiate the effect to anti-tumor drugs: Meanings of urokinase combination. Med. Postgrad.9, 1 (1971)
Yancey, S.T., Laki, K.: Transglutaminase and tumor growth. Ann. N.Y. Acad. Sci.202, 344 (1973)
Zöllner, N., Fellig, J.: Hemmung der Ribonuclease durch Heparin. Naturwissenschaften39, 523 (1952)
Author information
Authors and Affiliations
Additional information
Mit Unterstützung des „Landesverbandes Baden-Württemberg zur Erforschung und Bekämpfung des Krebses“
Rights and permissions
About this article
Cite this article
Heyes, H., Glück, D. Die Bedeutung des Fibrins/Fibrinogens für Wachstum und Metastasierung von Malignomen. Klin Wochenschr 55, 1079–1087 (1977). https://doi.org/10.1007/BF01477934
Issue Date:
DOI: https://doi.org/10.1007/BF01477934